---
figid: PMC3915522__nihms450216f5
figlink: /pmc/articles/PMC3915522/figure/F5/
number: F5
caption: Ras proteins function as nucleotide-driven switches that relay extracellular
  cues to cytoplasmic signalling cascades. The binding of GTP to Ras proteins locks
  them in their active states, which enables high affinity interactions with downstream
  targets that are called effectors. Subsequently, a slow intrinsic GTPase activity
  cleaves off the γ-phosphate, leading to Ras functional inactivation and thus the
  termination of signalling. This on–off cycle is tightly controlled by GTPase-activating
  proteins (GAPs) and guanine-nucleotide exchange factors (GEFs). GAPs, such as p120GAP
  or neurofibromin (NF1), enhance the intrinsic GTPase activity and hence negatively
  regulate Ras protein function. Conversely, GEFs (also known as GTP-releasing proteins/factors,
  termed GRPs or GRFs), such as RasGRF and son of sevenless (SOS), catalyse nucleotide
  ejection and therefore facilitate GTP binding and protein activation. The classical
  view of Ras signalling depicts Ras activation and recruitment to the plasma membrane
  following receptor Tyr kinase (RTK) stimulation by growth factors (GF). Activated
  Ras engages effector molecules — belonging to multiple effector families — that
  initiate several signal-transduction cascades. Outputs shown represent the main
  thrusts of the indicated pathways. Ras activation can also occur in endomembrane
  compartments, namely the endoplasmic reticulum and the Golgi. Activating mutations
  in the different components of the Ras–Raf–mitogen-activated protein kinase (MAPK)
  pathway are associated with the indicated developmental disorders, suggesting that
  MAPK-signal antagonism might be a rational approach to manage certain cardio-facio-cutaneous
  (CFC) syndromes. AF-6, acute lymphoblastic leukaemia-1 fused gene on chromosome
  6; CD1, cadherin domain-1; CDC42, cell division cycle-42; ELK, ETS-like protein;
  ERK, extracellular signal-regulated kinase; ETS, E26-transcription factor proteins;
  Ins(1,4,5)P3, inositol-1,4,5-trisphosphate; JNK, Jun N-terminal kinase; MEK, mitogen-activated
  protein kinase/ERK kinase; NF-κB, nuclear factor-κB; PI3K, phosphoinositide 3-kinase;
  PKB/C, protein kinase B/C; PLA/Cε/D, phospholipase A/Cε/D; RalBP1, Ral-binding protein-1;
  RASSF, Ras association domain-containing family; Rin1, Ras interaction/interference
  protein-1; SAPK, stress-activated protein kinase; SHP2, Src-homology-2 domain-containing
  protein Tyr phosphatase-2; TIAM1, T-cell lymphoma invasion and metastasis-1.
pmcid: PMC3915522
papertitle: 'Ras oncogenes: split personalities.'
reftext: Antoine E. Karnoub, et al. Nat Rev Mol Cell Biol. ;9(7):517-531.
pmc_ranked_result_index: '126738'
pathway_score: 0.9421793
filename: nihms450216f5.jpg
figtitle: 'Ras oncogenes: split personalities'
year: ''
organisms: Homo sapiens
ndex: f090a628-de9b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3915522__nihms450216f5.html
  '@type': Dataset
  description: Ras proteins function as nucleotide-driven switches that relay extracellular
    cues to cytoplasmic signalling cascades. The binding of GTP to Ras proteins locks
    them in their active states, which enables high affinity interactions with downstream
    targets that are called effectors. Subsequently, a slow intrinsic GTPase activity
    cleaves off the γ-phosphate, leading to Ras functional inactivation and thus the
    termination of signalling. This on–off cycle is tightly controlled by GTPase-activating
    proteins (GAPs) and guanine-nucleotide exchange factors (GEFs). GAPs, such as
    p120GAP or neurofibromin (NF1), enhance the intrinsic GTPase activity and hence
    negatively regulate Ras protein function. Conversely, GEFs (also known as GTP-releasing
    proteins/factors, termed GRPs or GRFs), such as RasGRF and son of sevenless (SOS),
    catalyse nucleotide ejection and therefore facilitate GTP binding and protein
    activation. The classical view of Ras signalling depicts Ras activation and recruitment
    to the plasma membrane following receptor Tyr kinase (RTK) stimulation by growth
    factors (GF). Activated Ras engages effector molecules — belonging to multiple
    effector families — that initiate several signal-transduction cascades. Outputs
    shown represent the main thrusts of the indicated pathways. Ras activation can
    also occur in endomembrane compartments, namely the endoplasmic reticulum and
    the Golgi. Activating mutations in the different components of the Ras–Raf–mitogen-activated
    protein kinase (MAPK) pathway are associated with the indicated developmental
    disorders, suggesting that MAPK-signal antagonism might be a rational approach
    to manage certain cardio-facio-cutaneous (CFC) syndromes. AF-6, acute lymphoblastic
    leukaemia-1 fused gene on chromosome 6; CD1, cadherin domain-1; CDC42, cell division
    cycle-42; ELK, ETS-like protein; ERK, extracellular signal-regulated kinase; ETS,
    E26-transcription factor proteins; Ins(1,4,5)P3, inositol-1,4,5-trisphosphate;
    JNK, Jun N-terminal kinase; MEK, mitogen-activated protein kinase/ERK kinase;
    NF-κB, nuclear factor-κB; PI3K, phosphoinositide 3-kinase; PKB/C, protein kinase
    B/C; PLA/Cε/D, phospholipase A/Cε/D; RalBP1, Ral-binding protein-1; RASSF, Ras
    association domain-containing family; Rin1, Ras interaction/interference protein-1;
    SAPK, stress-activated protein kinase; SHP2, Src-homology-2 domain-containing
    protein Tyr phosphatase-2; TIAM1, T-cell lymphoma invasion and metastasis-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAC1
  - PLD2
  - RHOG
  - RAB5A
  - PLD1
  - RASSF1
  - ACTA1
  - SORBS1
  - RAC2
  - RAC3
  - ACTG1
  - AKT3
  - PLD3
  - RALGDS
  - ACTG2
  - ACTB
  - ACTA2
  - AFDN
  - AKT1
  - RALA
  - ARAF
  - RALBP1
  - PLD5
  - ETS2
  - PLD6
  - PTPN11
  - MAPK1
  - PRKCE
  - ETS1
  - PRKCQ
  - PRKCD
  - BRAF
  - PLD4
  - CDC42
  - RALB
  - RINL
  - PRKD3
  - MAPK9
  - PRKCA
  - PRKCB
  - RASSF8
  - PRKCH
  - RAF1
  - PRKCZ
  - AKT2
  - ACTC1
  - RASSF9
  - TBCC
  - MAPK3
  - PIK3CA
  - PIK3R5
  - PIK3CB
  - PIK3CG
  - PIK3R3
  - PRKCG
  - PRKCI
  - RASSF7
  - PLCE1
  - RASSF4
  - RASSF2
  - PIK3R4
  - PIK3R6
  - CNTNAP1
  - PIK3CD
  - RASSF5
  - RASSF6
  - RASSF3
  - RHOD
  - NFKB1
  - MAPK10
  - RASSF10
  - MAPK8
  - Prostaglandins
  - Cancer
genes:
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD2
  entrez: '5338'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: RAB5
  symbol: RAB5
  source: hgnc_prev_symbol
  hgnc_symbol: RAB5A
  entrez: '5868'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD1
  entrez: '5337'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF1
  entrez: '11186'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: Ponsin
  symbol: ponsin
  source: hgnc_alias_symbol
  hgnc_symbol: SORBS1
  entrez: '10580'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD3
  entrez: '23646'
- word: RalGEF
  symbol: RalGEF
  source: hgnc_alias_symbol
  hgnc_symbol: RALGDS
  entrez: '5900'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: AF6
  symbol: AF-6
  source: hgnc_alias_symbol
  hgnc_symbol: AFDN
  entrez: '4301'
- word: AKT/PKB
  symbol: PKB
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ral
  symbol: RAL
  source: bioentities_symbol
  hgnc_symbol: RALA
  entrez: '5898'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RalBP1
  symbol: RALBP1
  source: hgnc_symbol
  hgnc_symbol: RALBP1
  entrez: '10928'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD5
  entrez: '200150'
- word: ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD6
  entrez: '201164'
- word: SHP2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD4
  entrez: '122618'
- word: -CDC42/
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: Ral
  symbol: RAL
  source: bioentities_symbol
  hgnc_symbol: RALB
  entrez: '5899'
- word: Rinl
  symbol: RINL
  source: hgnc_symbol
  hgnc_symbol: RINL
  entrez: '126432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: SAPK
  symbol: SAPK
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF8
  entrez: '11228'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: AKT/PKB
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Actin
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF9
  entrez: '9182'
- word: CFC
  symbol: CFC
  source: hgnc_alias_symbol
  hgnc_symbol: TBCC
  entrez: '6903'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF7
  entrez: '8045'
- word: PLCE
  symbol: PLCE
  source: hgnc_alias_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF4
  entrez: '83937'
- word: JNK/
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF2
  entrez: '9770'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: p190
  symbol: p190
  source: hgnc_alias_symbol
  hgnc_symbol: CNTNAP1
  entrez: '8506'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF5
  entrez: '83593'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF6
  entrez: '166824'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF3
  entrez: '283349'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: JNK/
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: RASSF
  symbol: RASSF
  source: bioentities_symbol
  hgnc_symbol: RASSF10
  entrez: '644943'
- word: JNK/
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
chemicals:
- word: Prostaglandins
  source: MESH
  identifier: D011453
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3915522__F5
redirect_from: /figures/PMC3915522__F5
figtype: Figure
---
